In a Press Release on February 16th, Imerys announced it has signed two commercial agreements with leading papermakers in Asia and the United States for production of FiberLean MFC, a mineral/micro-fibrillated cellulose (MFC) composite produced using a novel manufacturing technique. Imerys is planning on-site production plants for both papermakers, with a combined capacity for MFC of 8,000 metric tonnes annually. This now positions Imerys as one of the largest commercial suppliers of MFC in the world. The application of FiberLean MFC in paper and packaging offer producers the benefit of improved quality and strength for their products, while reducing cost
FiberLean MFC was recently approved by the U.S. Food and Drug Administration for food packaging applications as a food contact substance in paper and paperboard. The approval demonstrates its safety for such uses, as well as Imerys’ commitment to the responsible and safe development of its products.
To learn more about FiberLean, click here.
To read the full press release, click here.
To learn more about how Vireo Advisors can assist in demonstrating the safety of your products to ensure commercial success, contact us.